🔴 Korro Bio is trading 5% down today as inflation and market losses pressured growth-sensitive stocks

Korro Bio is trading at $8.34, down 5.33%, as hotter-than-expected September inflation and broad market losses pressured growth-sensitive stocks.

• No new company-specific catalyst was identified for October 14; the latest company announcement found was an October 5 clinical-trial update.
• The S&P 500 was down 1.11% and the Nasdaq was down 1.68%.
• The decline follows several consecutive down sessions in the provided price history.